John Derby Evans (born 1944)

https://en.wikipedia.org/wiki/John_D._Evans

2023-06-14-wikipedia-org-john -d-evans.pdf

John D. Evans

Nationality

American

Alma mater

University of Michigan

Occupation(s)

Business executive, philanthropist

Known for

Co-founder of C-SPAN

Parent(s)

Edward S. Evans, Jr

Relatives

Robert B. Evans

Awards

Courage in Business Award, Distinguished Alumnus Award

John D. Evans is an American business executive and philanthropist, best known for his role as one of the co-founders of the C-SPAN television network.[1]

Business career[edit]

Military[edit]

Evans served in the US Navy, achieving the rank of lieutenant during his career. He served aboard the aircraft carriers USS America and USS John F. Kennedy, was a television project head in the Navy project SEALAB, and served on the staff of the Chief of Naval Operations at The Pentagon.[2]

Telecommunications[edit]

Evans founded Evans Communications System after his career in the Navy, starting with two radio licenses in Charlottesville, Virginia. In 1972 he became a regional manager of the largest operating region of the predecessor of the Time Warner company, and eventually took the job of chief operating officer for Arlington Cable Partners. As an investor in the company, he helped build the first cable system in the Washington D.C. area.[3]

A 2016 inductee into the Cable Television Industry's Hall of Fame,[2] Evans is perhaps best known for his role in co-founding the public affairs cable network C-SPAN, which put cameras in the halls and legislature of the US Congress to document the legislative work of America's elected officials for the first time.[4] The network came about through a conversation he had with a former navy buddy of his Brian Lamb, who shared his idea of an all-Congress television station with Evans in July 1977. Evans then helped Lamb found and develop the network.[5] Evans' chief occupation at the time was President of Arlington TeleCommunications Corp, as he helped to expand the idea for a more locally oriented network to one that had major access to the halls of Congress.[6] In the 1980s, Evans also became President of Hauser Communications when it acquired Arlington TeleCommunications Corp and changed its name to Arlington Cable Partners,[2] and continued to serve on the board of C-SPAN. After being named Chairman of C-SPAN's Executive Committee (1992-1994), he helped draft a new plan named "C-SPAN 2000" to provide new strategic direction, implemented as Evans was chairman of the board for C-SPAN itself in the early 1990s.[2][7] During his tenure as Chairman, C-SPAN was the winner of several Golden Cable ACE awards, a Peabody Award, and a Golden Beacon Award.[8][9]

By the mid-1980s Evans was serving as chairman and CEO of Evans Telecommunications. He also served on the boards of the National Cable Television Association, the Washington Metropolitan Cable Club, and Falcon Cable Holdings.[10] Since helping to found C-SPAN, Evans has appeared on the network more than 100 times. Today he continues to serve as Chief Executive Officer and Chairman of Evans Telecommunications Co, The John D. Evans Foundation,[1] as Founding Director of the National Cable Satellite Corporation and Director of National Cable & Telecommunications Association.[11] He is also on the board of Internet2,[12] a consortium of 221 US Universities operating an 8.8 Terabit capacity research and education network. From 2013-2017, Evans was Industry representative to the board of Trustees of the Digital Preservation Network.[4] In 2009 Evans was named Entrepreneur of the Year by Washington & Jefferson College.[13]

In 2005 Evans was invited by Emory University to consult with Emory committees and serve on a Futurist Forum Panel to help Emory develop its strategic plan.[14]

Other Business Activities[edit]

In 1992, Evans bought Waterford Farm in Middleburg, Virginia and began breeding cattle.[10] He is also an investor and serves on the board of Accelerator Technology Holdings headquartered in Amman, Jordan. John also served as co-chair of Dr. Robert Gallo's Advisory Board at the Institute of Human Virology.[3]

Honors and awards[edit]

In 2009 Evans received the Courage in Business award from the National Gay & Lesbian Chamber of Commerce. In 2018 University of Maryland School of Medicine awarded him a lifetime-achievement award for public service.[11]

In 2019, he was honored with 2019 Distinguished Alumnus Award from University Liggett School.[3]

Personal life[edit]

Evans is the son of Edward S. Evans, Jr, former CEO of Evans Products Company,[15] nephew of Robert Beverley Evans, and grandson of Edward S. Evans Sr, who, in 1926, flew around the world in 28 days setting the world's record with pilot Linton Wells.[16] John Evans is a graduate of the University of Michigan,[1] and has homes in Sag Harbor, New York[17] and Ft. Lauderdale, Florida.[10]

References[edit]

External links[edit]



https://networthpost.org/net-worth/john-d-evans-net-worth/



John D. Evans Wiki: Salary, Married, Wedding, Spouse, Family

John D. Evans is an American business executive and philanthropist, best known for his role as one of the co-founders of the C-SPAN television network.



Net Worth

$700,000

Date Of Birth

1944-06-03

Profession

Miscellaneous Crew

Nicknames

John D. Evans, Evans, John D.


https://prabook.com/web/john_derby.evans/3605884

2023-06-14-prabook-com-john-derby-evans-3605884.pdf

2023-06-14-prabook-com-john-derby-evans-3605884-img-1.jpg


John Derby Evans Edit Profile

telecommunications industry executive

John Derby Evans, telecommunications industry executive. Named to Virginia Communications Hall of Fame, Richmond, Virginia, 2004; recipient Acquired Immune Deficiency Syndrome Achievement award, League African American Women, 2000, Lifetime Achievement award, University Maryland Institute Human Virology, 2007, Courage in Business award, National Gay & Lesiban Chamber of Commerce, 2009.

Background

Evans, John Derby was born on June 3, 1944 in Detroit, Michigan, United States. Son of Edward Steptoe and Florence (Allington) Evans.

Education

AB, University of Michigan, 1966.

Career

President Evans Communications Systems Inc., Charlottesville, Virginia, 1970-1972. Vice president, general manager Capitol Cablevision Corporation, Charleston, West Virginia, 1972-1976. Regional manager American television and Communications Corporation, Denver, 1974-1976.

Executive vice president, chief operating officer Arlington (Virginia) TeleCom. Corporation, 1976-1983. President Arlington Cable Partners Ltd., 1983-1994, Suburban Cable Partners, Brooklyn Park, Minnesota, 1985-1989, Hauser Communications, New York City, 1985-1994, Evans Telecomm.

Company, since 1983; chairman, Chief Executive Officer Waterford Marine Inc., The Plains, Virginia, 1996—2001. Staff assistant secretary planning and development Department Department of Health, Washington, 1976. Co-founder, board directors Cable Satellite Public Affairs Network (Cable-Satellite Public Affairs Network), since 1979, executive committee, 1982—1993, since 1998, chairman, 1991—1993, chairman finance committee, since 1997.

President Montgomery Cablevision (LP), Rockville, Maryland, 1986—1994, Washington Metro Cable Club, since 1981. Board directors Falcon Communications Company, Los Angeles, Falcon Cable television, 1998—2000, GBR Science, Baltimore, 1999—2000. Vice president North Central Cable Communications Company, Roseville, Minnesota, 1986—1992.

Managing general partner Waterford Farm Partnership, Middleburg, Virginia, since 1993. Siciliano forum lecturer University Utah, 1998. Future makers lecturer Emory University, 1999, futurist forum panelist, 2004.

Board directors Nelson Cable Company, Lovingston, Virginia. Lecturer Institute of the Humanities, University Michigan, 2000. Keynote speaker Executive Summit on International Health Philanthropy Royal College Physicians, London, 2001.

Inaugural lecturer Michigan State University Quello Center for Telecommunications Law and Regulation, 2001. Commencement speaker University Michigan, 2009. Board directors Alescentor Technology Holdings, Amman, Israel, since 2005.

Membership

Trustee C-Span Educational Foundation, since 1994. Trustee, vice chairman board trustees Signature Theater, Arlington, 1992—2004. Chairman board trustees Evans Foundation, since 1994.

Chairman Cancer/Acquired Immune Deficiency Syndrome Research Network, Baltimore. Member steering committee Institute Human Virology University Maryland, since 1996. Board director International Cancer and Acquired Immune Deficiency Syndrome Research Foundation, 1996—2000, International Acquired Immune Deficiency Syndrome Vaccine Initiative, New York City, since 2002, treasurer, since 2003, chairman finance and audit committee, since 2003, vice chairman, 2005—2008.

Board director Hollings Cancer Center, Charleston, South Carolina, 1998—2004. Advisory committee Acquired Immune Deficiency Syndrome Research Institute University California, San Francisco. Member visiting committee College Liberal Studies and A, University Michigan, since 1994, member president's advisory board, since 1998, member commission on information technical, since 2000.

Chairman Waterford Project Inc., 2000—2003. Treasurer International Acquired Immune Deficiency Syndrome Vaccine Initiative, since 2005. Board director Eisenhower World Affairs Institute, 1990—2003, chairman strategic planning committee, 1997—2003, vice chairman, 1999—2003.

Board director Accerator Technology Holdings, Amman, Jordan, since 2005. Member of Bank of America United States Trust Client Advisory Council, National Gay & Lesbian Chamber of Commerce (Courage in Business 2009), Cable television Administration, Marketing Society (board director 1985), Virginia Communication Hall of Fame, Virginia Commonwealth University Washington (Jefferson Entrepreneur of Year award 2009), Asia-Pacific Conference Science and Technology Leaders (United States delegate 1996), Virginia Cable Association (board director since 1979, vice president 1982, president 1983-1984, Hall of Fame 2001), National Cable television Association (national chairman awards committee 1981, board director since 1982, chairman government relations committee 1985-1986, member regulatory policy committee 1991-1995, chairman elections, bylaws committee 1991-1997, convention committee since 1998, member convention committee 1999—2000, President award 1979, Vanguard award 1984), Sag Harbor Yacht Club, Key West Yacht Club, Boars Head Sports Club (Charlottesville), Farmington Country Club (Inducted Virginia Communications Hall of Fame 2004).

Interests

Connections

Married Susan Blair Allan, April 7, 1973 (divorced November 1986). Children: John Derby, Courtenay Boyd.

Father:

Edward Steptoe Evans

Mother:

Florence (Allington) Evans

Spouse:

Susan Blair Allan

child:

Courtenay Boyd Evans

child:

John Derby Evans


2001 (Sep 17) - Forbes : "Outsmarting AIDS"

Robert Langreth   /   Sep 17, 2001,12:00am EDT

https://www.forbes.com/forbes/2001/0917/160.html?sh=5813e68c5289

2001-09-17-forbes-com-outsmarting-aids.pdf

2001-09-17-forbes-com-outsmarting-aids-img-1.jpg

2001-09-17-forbes-com-outsmarting-aids-img-160chart1-400-400.gif

Robert Gallo, the man who codiscovered the HIV virus, hopes a bold new approach may finally produce a vaccine to halt his killer.

Twenty years after the global outbreak of AIDS, no one has developed an effective vaccine against the HIV virus, a far more cunning foe than polio, smallpox or measles. Though at least 30 different candidate vaccines have been tested in humans, only one has advanced to the final stages, and most scientists are skeptical that this one will work.

Now comes Robert Gallo, codiscoverer of the HIV virus and director of the Institute of Human Virology in Baltimore, with a glimmer of hope. Researchers at his institute have devised a prototype vaccine that targets a vulnerable spot obscured by the surface of the virus. The vaccine appears to sidestep HIV's bedeviling ability to mutate and evade capture by the human immune system, a trait that has stymied efforts to concoct an effective inoculation. In tests on macaque monkeys, the vaccine produces potent antibodies that disable a variety of HIV strains from around the world, something previous vaccines have generally failed to do.

"This is like nothing we've seen before. It has neutralized almost all the strains we have tested, and we have tested a lot," Gallo says. Adds David Montefiori, a veteran AIDS researcher at Duke University Medical Center who has been evaluating how AIDS vaccines produce antibodies: "I've tested just about everything anybody has tried, and this is the best I've seen."

Now comes the hard part of translating this preliminary result into a vaccine suitable for large-scale human trials. In the past promising prototypes have often languished in the lab, partly because private-sector support for an AIDS vaccine has been limited. After all, selling one-shot vaccines to developing nations isn't as profitable as selling once-daily drugs to richer markets. But Gallo hopes to speed the vaccine forward with an innovative new collaboration called the Waterford Project, spearheaded by his entrepreneur friend John Evans, cofounder of C-SPAN.

The Waterford plan is to use broadband technology to link Gallo's lab with researchers at Harvard and the University of California at San Francisco and bring the new vaccine into human trials in as little as 18 months. Using Internet 2, an advanced version of today's network operating at up to 2.4 gigabits per second, the researchers will share early data as it is being developed, breaking down walls between otherwise competing labs.

The new vaccine was dreamed up almost a decade ago by Anthony DeVico, now a 44-year-old biochemist at Gallo's institute. Back then AIDS vaccine research was focused on stimulating the immune system to produce antibodies against the virus, a standard strategy that worked for polio and other diseases. But HIV is a master of disguise. The protein on the surface of the virus, called gp120, constantly mutates to escape detection by antibodies. The early results were so discouraging that some researchers concluded it would be impossible to devise a vaccine that fully blocked the infection.

In the early 1990s DeVico figured he might get around the mutation problem by targeting the crucial portion of gp120 that is normally obscured by HIV's surface. This portion doesn't mutate much; the virus uses it to hijack human blood cells and reproduce itself. But gp120's innards are exposed for 30 minutes or so while the protein is hooked to its human receptor, called CD4, in preparation to invade a cell. DeVico's idea was to build a vaccine consisting of gp120 permanently fused to its CD4 receptor. He figured shots of this fused vaccine would prompt the immune system to create an army of antibodies motivated to sniff out and disable the virus in its exposed position during that crucial 30-minute period.

The concept was so far off the beaten track, hardly anyone paid attention at first, but his recent tests of the vaccine in monkeys are generating excitement among the few researchers who have seen the data. In the tests DeVico and his colleagues inoculated several monkeys with the gp120-CD4 vaccine, then tested their blood against HIV in a test tube. Sure enough, the blood contained antibodies that disabled a spectrum of strains from Africa, North America and elsewhere. DeVico won't discuss details of his study pending publication.

In the meantime Gallo and Evans had already formed the Waterford Project, which arose from Gallo's frustration with the pace of vaccine research and his desire to bring scattered researchers together. Evans suggested that high-speed data links could help far-flung labs share results.

In 1999 Evans brought together Gallo and a handful of scientists and Internet experts at his Virginia farm, Waterford House, to discuss the idea. Initially the scientists were uneasy. "In research you plant a flag and defend your turf. We were not natural collaborators," explains Warner Greene, who directs San Francisco's Gladstone Institute of Virology & Immunology. But over time the egos faded, and the scientists realized how much faster they could progress by cooperating. The possibility of making history for producing the vaccine that wiped out AIDS didn't hurt either. "It has been the most exciting single enterprise I have been involved with," says Greene. When Gallo showed the DeVico data in person to his Waterford collaborators less than a year ago, they quickly agreed to make it a top priority. "The more I looked at the data, the more excited I became," says Greene. As a first step Waterford is now installing videoconferencing equipment.

Much remains to be done to confirm the finding and turn it into a practical vaccine. The researchers need to perform a more realistic test to see if the vaccine indeed protects monkeys exposed to an AIDS-like virus. They must tinker with the vaccine to boost the quantity of antibodies it makes, figure out a reliable production process and prove it is safe to use in millions of patients. Stimulating the production of antibodies--only one arm of the immune system--may not be enough. Ultimately, researchers will likely want to combine it with one of the vaccines being developed to stimulate production of killer T cells.

Despite all the promise, the group is still short on money. The original Waterford plan, conceived at the height of the bull market, was to raise money from telecom firms using Evans' connections. But with the market slump, those money sources have dried up. Evans has donated $1.5 million of his own, but that is a fraction of the planned $14 million annual budget. Gallo's lab has government funds to continue its vaccine work, but it will go faster with several labs working together.

For Waterford collaborator [Dr. Myron Elmer "Max" Essex (born 1939)] of the Harvard School of Public Health, a vaccine can't come soon enough. Essex, advance man for human trials, is spending this fall in Botswana, where 38% of adults are already infected. "It's unbelievably urgent," he says. "What do you do if you want to have kids and get married?" A vaccine won't cure the 36 million already infected, but every day HIV claims 15,000 more.